Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders.

A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell engager (TCE) for autoimmune disorders in ...

It is known that bacterial cells exchange biological matter, but it is not clear whether bacteria can exchange functional ...

Awards are an honor, but they are not why we do what we do. That's why this year's recognition from the APEX Awards is especially meaningful. BioWorld earned seven 2026 APEX Awards, including three ...